Comparative Pathology of Murine Mucolipidosis Types II and IIIC

UDP-GlcNAc: lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (GlcNAc-1-phosphotransferase) is an α2β2γ2 hexameric enzyme that catalyzes the first step in the synthesis of the mannose 6-phosphate targeting signal on lysosomal hydrolases. In humans, mutations in the gene encoding the α/β subunit precursor give rise to mucolipidosis II (MLII), whereas mutations in the gene encoding the γ subunit cause the less severe mucolipidosis IIIC (MLIIIC). In this study we describe the phenotypic, histologic, and serum lysosomal enzyme abnormalities in knockout mice lacking the γ subunit and compare these findings to those of mice lacking the α/β subunits and humans with MLII and MLIIIC. We found that both lines of mutant mice had elevated levels of serum lysosomal enzymes and cytoplasmic alterations in secretory cells of several exocrine glands; however, lesions in γ-subunit deficient (Gnptab -/-) mice were milder and more restricted in distribution than in α/β-subunit deficient (Gnptab -/-) mice. We found that onset, extent, and severity of lesions that developed in these two different knockouts correlated with measured lysosomal enzyme activity; with a more rapid, widespread, and severe storage disease phenotype developing in Gnptab -/- mice. In contrast to mice deficient in the α/β subunits, the mice lacking the γ subunits were of normal size, lacked cartilage defects, and did not develop retinal degeneration. The milder disease in the γ-subunit deficient mice correlated with residual synthesis of the mannose 6-phosphate recognition marker. Of significance, neither strain of mutant mice developed cytoplasmic vacuolar inclusions in fibrocytes or mesenchymal cells (I-cells), the characteristic lesion associated with the prominent skeletal and connective tissue abnormalities in humans with MLII and MLIII. Instead, the predominant lesions in both lines of mice were found in the secretory epithelial cells of several exocrine glands, including the pancreas, and the parotid, submandibular salivary, nasal, lacrimal, bulbourethral, and gastric glands. The absence of retinal and chondrocyte lesions in Gnptab -/- mice might be attributed to residual β-glucuronidase activity. We conclude that mice lacking either α/β or γ subunits displayed clinical and pathologic features that differed substantially from those reported in humans having mutations in orthologous genes.

[1]  D. Rice,et al.  Mice Lacking α/β Subunits of GlcNAc-1-Phosphotransferase Exhibit Growth Retardation, Retinal Degeneration, and Secretory Cell Lesions , 2007 .

[2]  P. Vogel,et al.  Murine UDP-GlcNAc:Lysosomal Enzyme N-Acetylglucosamine-1-phosphotransferase Lacking the γ-Subunit Retains Substantial Activity toward Acid Hydrolases* , 2007, Journal of Biological Chemistry.

[3]  S. Chung,et al.  Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-beta-glucosidase. , 2007, Biochemical pharmacology.

[4]  M. Sands,et al.  Clinical response to persistent, low-level β-glucuronidase expression in the murine model of mucopolysaccharidosis type VII , 2007, Journal of Inherited Metabolic Disease.

[5]  H. Mandel,et al.  When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients. , 2006, Molecular genetics and metabolism.

[6]  W. Canfield,et al.  Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene. , 2006, American journal of human genetics.

[7]  B. Roe,et al.  The α- and β-subunits of the Human UDP-N-acetylglucosamine:Lysosomal Enzyme Phosphotransferase Are Encoded by a Single cDNA* , 2005, Journal of Biological Chemistry.

[8]  C. Ki,et al.  Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc‐phosphotransferase α/β subunits in Korean patients with mucolipidosis type II or type IIIA , 2005, Human mutation.

[9]  Mahindra T. Makhija,et al.  Correlation between inactive cathepsin D expression and retinal changes in mcd2/mcd2 transgenic mice. , 2005, Investigative ophthalmology & visual science.

[10]  R. Ramirez-Solis,et al.  Saturation Screening of the Druggable Mammalian Genome , 2005 .

[11]  A. Toutain,et al.  Genomic organisation of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III , 2004, Journal of Medical Genetics.

[12]  Peter Vogel,et al.  Wnk1 kinase deficiency lowers blood pressure in mice: A gene-trap screen to identify potential targets for therapeutic intervention , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Aguirre,et al.  Inheritance, biochemical abnormalities, and clinical features of feline mucolipidosis II: the first animal model of human I-cell disease. , 2003, The Journal of heredity.

[14]  S. Kornfeld,et al.  Mannose 6-phosphate receptors: new twists in the tale , 2003, Nature Reviews Molecular Cell Biology.

[15]  H. Nakanishi,et al.  Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice , 2003, Molecular and Cellular Neuroscience.

[16]  I. Constable,et al.  Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. , 2002, The American journal of pathology.

[17]  S. Kornfeld,et al.  Human Mannose 6-Phosphate-uncovering Enzyme Is Synthesized as a Proenzyme That Is Activated by the Endoprotease Furin* , 2002, The Journal of Biological Chemistry.

[18]  B. Roe,et al.  Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC) , 2000, The Journal of clinical investigation.

[19]  I. Constable,et al.  Distribution of cathepsin D in human eyes with or without age-related maculopathy. , 1999, Experimental eye research.

[20]  K. von Figura,et al.  Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific. , 1999, Journal of cell science.

[21]  D. Birch Retinal degeneration in retinitis pigmentosa and neuronal ceroid lipofuscinosis: An overview. , 1999, Molecular genetics and metabolism.

[22]  M. Elleder,et al.  Mucolipidosis type II with evidence of a novel storage site , 1998, Virchows Archiv.

[23]  K. Figura,et al.  I-cell disease-like phenotype in mice deficient in mannose 6-phosphate receptors , 1998, Transgenic Research.

[24]  P. Arvan,et al.  Sorting and storage during secretory granule biogenesis: looking backward and looking forward. , 1998, The Biochemical journal.

[25]  D. Weix,et al.  Molecular Basis of Lysosomal Enzyme Recognition: Three-Dimensional Structure of the Cation-Dependent Mannose 6-Phosphate Receptor , 1998, Cell.

[26]  P. Arvan,et al.  Mannose 6–Phosphate Receptors Are Sorted from Immature Secretory Granules via Adaptor Protein AP-1, Clathrin, and Syntaxin 6–positive Vesicles , 1998, The Journal of cell biology.

[27]  T. Ludwig,et al.  Differential Sorting of Lysosomal Enzymes Out of the Regulated Secretory Pathway in Pancreatic β-Cells , 1997, The Journal of cell biology.

[28]  J. Booth,et al.  Bovine UDP-N-acetylglucosamine:Lysosomal-enzyme N-Acetylglucosamine-1-phosphotransferase I , 1996, The Journal of Biological Chemistry.

[29]  K. von Figura,et al.  Spontaneous Mucolipidosis in a Cat: An Animal Model of Human I-Cell Disease , 1996, Veterinary pathology.

[30]  J. Glickman,et al.  Mannose 6-phosphate-independent targeting of lysosomal enzymes in I- cell disease B lymphoblasts , 1993, The Journal of cell biology.

[31]  W. Sly,et al.  Photoreceptor degeneration and altered distribution of interphotoreceptor matrix proteoglycans in the mucopolysaccharidosis VII mouse. , 1993, Experimental eye research.

[32]  G. Beluffi,et al.  Bone changes of mucolipidosis II at different ages. Postmortem study of three cases. , 1992, Clinical orthopaedics and related research.

[33]  T. Hirano,et al.  Pancreatic lysosomal enzyme secretion via gut-hormone-regulated pathway in rats. , 1991, Nihon geka hokan. Archiv fur japanische Chirurgie.

[34]  M. Tamai,et al.  Immunohistochemical localization of cathepsin D in ocular tissues. , 1990, Investigative ophthalmology & visual science.

[35]  G. Aguirre,et al.  Beta-glucuronidase mediated pathway essential for retinal pigment epithelial degradation of glycosaminoglycans. Disease expression and in vitro disease correction using retroviral mediated cDNA transfer. , 1990, Experimental eye research.

[36]  A. Adler,et al.  Selective presence of acid hydrolases in the interphotoreceptor matrix. , 1989, Experimental eye research.

[37]  M. Davisson,et al.  Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. , 1989, The Journal of clinical investigation.

[38]  Y. Suzuki,et al.  I-cell disease: evidence for a mannose 6-phosphate independent pathway for translocation of lysosomal enzymes in lymphoblastoid cells. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[39]  J. Martín,et al.  I-cell disease , 1984, Acta Neuropathologica.

[40]  D. Goldberg,et al.  Identification and characterization of cells deficient in the mannose 6-phosphate receptor: evidence for an alternate pathway for lysosomal enzyme targeting. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Varki,et al.  Demonstration of the heterozygous state for I-cell disease and pseudo-Hurler polydystrophy by assay of N-acetylglucosaminylphosphotransferase in white blood cells and fibroblasts. , 1982, American journal of human genetics.

[42]  M. Owada,et al.  Is there a mechanism for introducing acid hydrolases into liver lysosomes that is independent of mannose 6-phosphate recognition? Evidence from I-cell disease. , 1982, Biochemical and biophysical research communications.

[43]  A. Varki,et al.  Identification of a variant of mucolipidosis III (pseudo-Hurler polydystrophy): a catalytically active N-acetylglucosaminylphosphotransferase that fails to phosphorylate lysosomal enzymes. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[44]  W. Sly,et al.  Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Hayasaka,et al.  Degradation of rod outer segment proteins by cathepsin D. , 1975, Journal of biochemistry.

[46]  D. Rice,et al.  Mice lacking alpha/beta subunits of GlcNAc-1-phosphotransferase exhibit growth retardation, retinal degeneration, and secretory cell lesions. , 2007, Investigative ophthalmology & visual science.

[47]  B. Henrissat,et al.  Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. , 2005, Nature medicine.

[48]  S. Kornfeld Trafficking of lysosomal enzymes in normal and disease states. , 1986, The Journal of clinical investigation.